8 weeks 2 x 10 mL bottles 4-6 vials use 12-18 mL
Current Research Focus Areas Animal studies investigate BPC 157 effects on tendon and ligament injuries
Scientists have figured out how the new weight-loss drug, Retatrutide, works at a molecular level
Durham Peptides ships BPC-157 in protective packaging with same-day dispatch from Ontario
Eddie works with you to build sustainable nutrition habits, optimize your hormone levels, and address underlying metabolic factors during your active treatment phase
The rates are remarkably similar across all three, despite their different mechanisms: Semaglutide: Nausea approximately 18%, diarrhea approximately 12%, vomiting approximately 8% Tirzepatide: Nausea 17-22% (dose dependent), diarrhea 13-16%, vomiting 6-10% Retatrutide: Nausea 16-25% (dose dependent), diarrhea 15-22%, vomiting 8-13% The pattern holds consistently